mRNA Vaccine and Therapeutics Market Trends, Opportunities, Key Players, Growth Factors, Revenue Analysis, 2024-2035

This report presents a detailed, data-driven analysis of the global mRNA Vaccine and Therapeutics Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global mRNA vaccine and therapeutics market, valued at USD 9 million in 2026 , is projected to reach USD 17,036 million by 2035 , representing a high CAGR during the forecast period 2026 to 2035.

Market Segmentation

- Historical Trend: Since 2023

- Forecast Period: Till 2035

- Market Size 2026: USD 9 Million

- Market Size 2035: USD 17,036 Million

- Key Players Profiled

• Moderna

• BioNTech

• Providence Therapeutics

• Suzhou Abogen Biosciences

• CureVac

• RNAimmune (Subsidiary of Sirnaomics)

• Turn Biotechnologies

• Arcturus Therapeutics

• Walvax

- Segments Covered

• Application Area

• Target Disease Indication

• Geographical Regions

Read More: https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html

Key Geographies

North America

Europe

Asia-Pacific

Middle East and North Africa

Latin America

Each segment is analyzed by volume, value, and growth patterns, offering a comparative understanding of usage trends and market opportunities.

Analytical Insights Covered

▪ Market Landscape

▪ Product Competitiveness Analysis

▪ Partnership and Collaboration Analysis

▪ Funding and Investment Analysis

▪ Go-No-Go Framework

▪ Patent Analysi